# Cannabis and Stroke Risk: Texas Expands Access March 2026 > **Author:** Benjamin Caplan, MD (ABFM Board Certified, MA Lic. #240562, NPI: 1962722637) > **Publisher:** CED Clinic (https://cedclinic.com) > **Canonical URL:** https://cedclinic.com/cannabis-and-stroke-risk-texas-expands-access-march-2026/ > **Published:** 2026-03-09T09:15:03-04:00 | **Last Modified / Clinically Audited:** 2026-09-28T11:10:08-04:00 > **Clinical Summary:** Explore the latest on cannabis and stroke risk, including Texas expanding medical cannabis access and new insights on edible pharmacokinetics. --- Last 10 Hours March 09, 2026 — 7 articles reviewed This cycle’s dominant story is a single Cambridge University study linking recreational drug use to significantly elevated stroke risk, particularly in younger populations, which received extensive media coverage across multiple major outlets. Alongside that, infrastructure expansion in Texas and a closer look at edible [cannabis pharmacokinetics](https://cedclinic.com/india-medicinal-cannabis-trials-human-research-launch/) round out a feed that balances safety concerns with practical access and dosing realities. Jump to section[Stroke Risk and Recreational Drug Use: One Study, Major Implications](#stroke-risk-and-recreational-drug-use-on)[Texas Expands Medical Cannabis Infrastructure](#texas-expands-medical-cannabis-infrastru)[Edible Cannabis Pharmacokinetics and the Liver Factor](#edible-cannabis-pharmacokinetics-and-the)[Industry Pivot Toward Medical Standardization](#industry-pivot-toward-medical-standardiz) The Cambridge stroke data is a reminder that cannabis carries real cardiovascular risk that we must communicate honestly, especially to younger patients who assume safety from legality. Good medicine means holding two truths at once: cannabis has genuine therapeutic value for many patients, and it demands the same individualized [risk assessment](https://cedclinic.com/ethical-legal-dilemmas-cannabis-use/) we apply to every other intervention in our toolkit. Browse all recent articles at [cedclinic.com/category/cannabis-news/](https://cedclinic.com/category/cannabis-news/) Further Reading Evidence Watch[The Brain Science Behind the Munchies – Nautilus Magazine](https://cedclinic.com/cannabis-appetite-stimulation-neuroscience/) Evidence WatchIGC Pharma Adds Visionary Investigators Network as Clinical Site to Phase 2 CALMA Trial Cannabis Policy Wire[Policy Watch: 20 Regulatory Updates — March 10, 2026](https://cedclinic.com/dea-scheduling-synthetic-opioids-regulatory-updates-2026/) [https://cedclinic.com/contact/](https://cedclinic.com/contact/) Physician-Led, Whole-Person Care A doctor who takes the time to truly understand you. Personal care that starts with listening and is guided by experience and ingenuity. Health, Longevity, Wellness One-on-One Cannabis Guidance Metabolic Balance [Leave a Message](https://cedclinic.com/contact/) [Metabolic Care](https://cedclinic.com/metabolic/metabolic-how-it-works/) [Medical Consulting](https://cedclinic.com/book/) [Cannabis Care](https://cedclinic.com/book/) [https://cedclinic.com/contact/](https://cedclinic.com/contact/) RELATED READING AT CED CLINIC Continue exploring the evidence [Daily Digest: Last 9 Hours: Stroke Risk From Recreational Drugs and DEA Scheduling Actions — March 08, 2026](https://cedclinic.com/daily-digest-last-9-hours-stroke-risk-from-recreational-drugs-and-dea-scheduling-actions-march-08-2026/) Review recent findings on stroke risk linked to recreational drugs and regulatory updates impacting cannabis scheduling. [Read More](https://cedclinic.com/daily-digest-last-9-hours-stroke-risk-from-recreational-drugs-and-dea-scheduling-actions-march-08-2026/) [Daily Digest: Last 2 Hours: Stroke Risk, Industry Maturation, and Reassurance for Older Adults — March 09, 2026](https://cedclinic.com/daily-digest-last-2-hours-stroke-risk-industry-maturation-and-reassurance-for-older-adults-march-09-2026/) Explore the latest stroke risk data and industry developments providing reassurance for older adult cannabis users. [Explore Now](https://cedclinic.com/daily-digest-last-2-hours-stroke-risk-industry-maturation-and-reassurance-for-older-adults-march-09-2026/) [Daily Digest: Last 9 Hours: Cognitive Safety Signals, Adolescent Risk, and the Regulatory Puzzle That Still Defines Cannabis Medicine — March 03, 2026](https://cedclinic.com/age-dependent-cannabis-cognitive-effects-clinical-insights/) Delve into cognitive safety and adolescent risk factors shaping [cannabis medicine](https://cedclinic.com/essential-oils-industrial-hemp-antimicrobial-benefits/) regulations and [clinical practice](https://cedclinic.com/cannabis-reproductive-health-women-clinical-evidence/). [Learn More](https://cedclinic.com/age-dependent-cannabis-cognitive-effects-clinical-insights/) Have thoughts on this? Share it: [X Share on X](https://twitter.com/intent/tweet?text=Daily%20Digest%3A%20Cannabis%20and%20Stroke%20Risk%20in%20Focus%20as%20Texas%20Expands%20Access%20%E2%80%94%20March%2009%2C%202026&url=https%3A%2F%2Fcedclinic.com%2Fcannabis-and-stroke-risk-texas-expands-access-march-2026%2F) [in Share on LinkedIn](https://www.linkedin.com/sharing/share-offsite/?url=https%3A%2F%2Fcedclinic.com%2Fcannabis-and-stroke-risk-texas-expands-access-march-2026%2F) [Share on BlueSky](https://bsky.app/intent/compose?text=Daily%20Digest%3A%20Cannabis%20and%20Stroke%20Risk%20in%20Focus%20as%20Texas%20Expands%20Access%20%E2%80%94%20March%2009%2C%202026%20https%3A%2F%2Fcedclinic.com%2Fcannabis-and-stroke-risk-texas-expands-access-march-2026%2F) [Follow on Instagram](https://www.instagram.com/drbenjamincaplan) [Read more on Substack](https://doctorapprovedcannabis.substack.com/) [Subscribe via RSS](https://cedclinic.com/feed/) ### Related --- ### Verification & Medical Governance - **Lead Clinical Author:** Benjamin Caplan, MD - **Credentials:** Board Certified in Family Medicine (ABFM), Former CMO Canna Care Docs (250,000+ patients supervised), Founder & CMO CED Clinic & CED Foundation, Author of *The Doctor-Approved Cannabis Handbook* (Penguin Random House). - **Clinical Scale:** 350,000+ lifetime evaluations overseen; 81,008-patient Real-World Evidence Registry (`~/.ced_rwe_vault.db`); 125,000+ peer-reviewed study literature observatory (`http://localhost:8768/api/explorer/terminal`). - **License Verification:** Commonwealth of Massachusetts License #240562 (https://checkahealthlicense.mass.gov/). - **NPI Registry:** 1962722637 (https://npiregistry.cms.hhs.gov/provider-view/1962722637). - **Ethics & Data Privacy:** Clinical registry observations adhere strictly to HIPAA Safe Harbor de-identification (45 CFR § 164.514(b)) and criteria for secondary research exemption under 45 CFR § 46.104(d)(4).